Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.

Published on Nov 1, 2016in Neuro-oncology10.247
· DOI :10.1093/NEUONC/NOW063
Carrie R. McDonald38
Estimated H-index: 38
,
Rachel L. Delfanti5
Estimated H-index: 5
+ 11 AuthorsNikdokht Farid17
Estimated H-index: 17
Sources
Abstract
Diffusion-weighted imaging has shown initial promise for evaluating response to bevacizumab in patients with high-grade glioma (HGG). However, it is well recognized that the apparent diffusion coefficient (ADC) is influenced by bevacizumab-induced reductions in edema, which may limit its prognostic value. We demonstrate that an advanced diffusion-weighted imaging technique, restriction spectrum imaging (RSI), improves the evaluation of response to bevacizumab because unlike ADC, RSI is not affected by resolution of edema.RSI and ADC maps were analyzed for 40 patients with HGG prior to and following initiation of bevacizumab. Volumes of interest were drawn for regions of contrast enhancement (CE) and fluid attenuated inversion recovery (FLAIR) hyperintensity and histogram percentiles within volumes of interest were calculated for ADC 10th percentile (ADC-CE10%, ADC-FLAIR10%) and for RSI 90th percentile (RSI-CE90%, RSI-FLAIR90%). Cox proportional hazard models were used to evaluate the relationship between imaging parameters, progression-free survival (PFS), and overall survival (OS).An increase in RSI-FLAIR90% following bevacizumab was the strongest predictor of poor PFS (P= .016) and OS (P= .004), whereas decreases in ADC-FLAIR10% showed a weaker association with OS only (P= .041). Within the CE region, increases in RSI-CE90% alone were associated with poorer OS. Correlational analysis revealed that decreases in FLAIR volume were associated with decreases in ADC-FLAIR10%, but not with changes in RSI-FLAIR90%.RSI is less influenced by changes in edema, conferring an advantage of RSI over ADC for evaluating response to anti-angiogenic therapy in patients with HGG.
Download
📖 Papers frequently viewed together
2,421 Citations
6 Citations
64 Citations
References43
Newest
#1Myron Zhang (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 1
#2Bryanna Gulotta (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 1
Last. Robert J. YoungH-Index: 101
view all 12 authors...
Glioblastomas treated with bevacizumab may develop low-signal apparent diffusion coefficient (low-ADC) lesions, which may reflect increased tumor cellularity or atypical necrosis. The purpose of this study was to examine the relationship between low-ADC lesions and overall survival (OS). We hypothesized that growing low-ADC lesions would be associated with shorter OS.We retrospectively identified 52 patients treated with bevacizumab for the first (n = 42, 81%) or later recurrence of primary glio...
20 CitationsSource
#1Wolfgang Wick (DKFZ: German Cancer Research Center)H-Index: 123
#2Aa. Brandes (AUSL: Academy for Urban School Leadership)H-Index: 1
Last. M. J. van den BentH-Index: 43
view all 20 authors...
LB-05. PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL W. Wick1, AA. Brandes2, T. Gorlia3, M. Bendszus1, F. Sahm1, W. Taal4, M. Taphoorn5, J. Domont6, A. Idbaih7, M. Campone8, P.M. Clement9, R. Stupp10, M. Fabbro11, F. Dubois12, C. Bais13, D. Musmeci3, M. Platten1, M. Weller10, V. Golfinopoulos3, and M. van den Bent4; University Medical Center & German Cancer Research Center, Heidelberg, Germany; Me...
71 CitationsSource
In these days of individualized precision medicine and “big data” generated by means of next-generation sequencing, there are expectations that new therapeutic strategies for cancer will be quickly conceived and then realized in the clinic. Next-generation sequencing has certainly provided new insights into some cancers, stimulating the study of underlying biologic mechanisms and the development of targeted treatments. But even when whole-genome sequencing reveals that the genetic landscape of a...
21 CitationsSource
#1Benjamin M. Ellingson (UCLA: University of California, Los Angeles)H-Index: 52
#2Eunhee Kim (Brown University)H-Index: 7
Last. Daniel P. Barboriak (Duke University)H-Index: 34
view all 13 authors...
Functional diffusion mapping (fDM) is a cancer imaging technique that quantifies voxelwise changes in apparent diffusion coefficient (ADC). Previous studies have shown value of fDMs in bevacizumab therapy for recurrent glioblastoma multiforme (GBM). The aim of the present study was to implement explicit criteria for diffusion MRI quality control and independently evaluate fDM performance in a multicenter clinical trial (RTOG 0625/ACRIN 6677). A total of 123 patients were enrolled in the current ...
35 CitationsSource
#1Qiuting Wen (UCSF: University of California, San Francisco)H-Index: 5
#2Laleh Jalilian (UCSF: University of California, San Francisco)H-Index: 1
Last. Sarah J. Nelson (UCSF: University of California, San Francisco)H-Index: 93
view all 8 authors...
To evaluate metrics that describe changes in apparent diffusion coefficient (ADC) and to examine their association with clinical outcome for patients with newly diagnosed GBM who were participating in a Phase II clinical trial of treatment with radiation (RT), temozolomide, erlatonib and bevacizumab. Thirty six patients were imaged after surgery but prior to therapy and at regular follow-up time points. The following ADC metrics were evaluated: (1) histogram percentiles within the T2-hyperintens...
30 CitationsSource
#1Benjamin M. Ellingson (UCLA: University of California, Los Angeles)H-Index: 52
Radiogenomics is a provocative new area of research based on decades of previous work examining the association between radiological and histological features. Many generalized associations have been established linking anatomical imaging traits with underlying histopathology, including associations between contrast-enhancing tumor and vascular and tumor cell proliferation, hypointensity on pre-contrast T1-weighted images and necrotic tissue, and associations between hyperintensity on T2-weighte...
91 CitationsSource
#1Nathan S. White (UCSD: University of California, San Diego)H-Index: 28
#2Carrie R. McDonald (UCSD: University of California, San Diego)H-Index: 38
Last. Anders M. Dale (UCSD: University of California, San Diego)H-Index: 166
view all 26 authors...
Diffusion-weighted imaging (DWI) has been at the forefront of cancer imaging since the early 2000s. Before its application in clinical oncology, this powerful technique had already achieved widespread recognition due to its utility in the diagnosis of cerebral infarction. Following this initial success, the ability of DWI to detect inherent tissue contrast began to be exploited in the field of oncology. Although the initial oncologic applications for tumor detection and characterization, assessi...
111 CitationsSource
#1Nikdokht Farid (UCSD: University of California, San Diego)H-Index: 17
#2Daniela B. Almeida-Freitas (USP: University of São Paulo)H-Index: 2
Last. Anders M. Dale (UCSD: University of California, San Diego)H-Index: 166
view all 10 authors...
A subset of patients with high-grade glioma and brain metastases who are treated with bevacizumab develop regions of marked and persistent restricted diffusion that do not reflect recurrent tumor. Here, we quantify the degree of restricted diffusion and the relative cerebral blood volume (rCBV) within these regions of bevacizumab-related imaging abnormality (BRIA) in order to facilitate differentiation of these lesions from recurrent tumor. Six patients with high-grade glioma and two patients wi...
9 CitationsSource
#1Rifaquat Rahman (Harvard University)H-Index: 10
#2Alhafidz Hamdan (Brigham and Women's Hospital)H-Index: 8
Last. Raymond Y. Huang (Brigham and Women's Hospital)H-Index: 29
view all 9 authors...
While patients with recurrent glioblastoma receiving anti-angiogenic therapy demonstrate significant response rates, the benefit on patient survival is less clear. We assessed whether histogram analysis of diffusion weighted MRI can stratify for progression-free and overall survival. Baseline and 3–6 week post-treatment MRI exams of 91 patients with recurrent glioblastoma treated with bevacizumab were retrospectively evaluated. Histograms of apparent diffusion coefficient (ADC) within the volume...
36 CitationsSource
#2Solmaz Sahebjam (U of T: University of Toronto)H-Index: 16
Last. Timothy F. Cloughesy (UCLA: University of California, Los Angeles)H-Index: 120
view all 10 authors...
BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determine whether ADC histogram analysis is a bevacizumab-specific or treatment-independent biomarker of treatment response in recurrent glioblastoma multiforme. MATERIALS AND METHODS: Eighty-nine bevacizumab...
49 CitationsSource
Cited By25
Newest
#1Chun Chieh Fan (UCSD: University of California, San Diego)H-Index: 26
#2R. J. Loughnan (UCSD: University of California, San Diego)H-Index: 4
Last. Ole A. Andreassen (Oslo University Hospital)H-Index: 123
view all 11 authors...
The molecular determinants of tissue composition of the human brain remain largely unknown. Recent genome-wide association studies (GWAS) on this topic have had limited success due to methodological constraints. Here, we apply advanced whole-brain analyses on multi-shell diffusion imaging data and multivariate GWAS to two large scale imaging genetic datasets (UK Biobank and the Adolescent Brain Cognitive Development study) to identify and validate genetic association signals. We discovered 503 u...
Source
#1Chun Chieh Fan (UCSD: University of California, San Diego)H-Index: 26
#2R. J. Loughnan (UCSD: University of California, San Diego)H-Index: 4
Last. Anders M. Dale (UCSD: University of California, San Diego)H-Index: 166
view all 10 authors...
It is important to understand the molecular determinants for microstructures of human brain. However, past genome-wide association studies (GWAS) on microstructures of human brain have had limited results due to methodological constraints. Here, we adopt advanced imaging processing methods and multivariate GWAS on two large scale imaging genetic datasets (UK Biobank and Adolescent Brain Cognitive Development study) to identify and validate key genetic association signals. We discovered 503 uniqu...
Source
Glioblastoma (GBM) is the most malignant brain tumor in adults, with a dismal prognosis despite aggressive multi-modal therapy. Immunotherapy is currently being evaluated as an alternate treatment modality for recurrent GBMs in clinical trials. These immunotherapeutic approaches harness the patient’s immune response to fight and eliminate tumor cells. Standard MR imaging is not adequate for response assessment to immunotherapy in GBM patients even after using refined response assessment criteria...
1 CitationsSource
#1Emilie T. Reas (UCSD: University of California, San Diego)H-Index: 13
#2Gail A. Laughlin (UCSD: University of California, San Diego)H-Index: 65
Last. Linda K. McEvoy (UCSD: University of California, San Diego)H-Index: 66
view all 6 authors...
Midlife vascular disease increases risk for dementia and effects of vascular dysfunction on brain health differ between men and women. Elevated pulse pressure, a surrogate for arterial stiffness, contributes to cerebrovascular pathology and white matter damage that may advance cognitive aging; however, it remains unclear how associations between pulse pressure and neural integrity differ by sex and age. This study used restriction spectrum imaging to examine associations between pulse pressure a...
Source
#1M. Muge Karaman (UIC: University of Illinois at Chicago)H-Index: 9
#2Jiaxuan Zhang (HUST: Huazhong University of Science and Technology)H-Index: 3
Last. Xiaohong Joe ZhouH-Index: 28
view all 5 authors...
The purpose of this study is to investigate the feasibility of using a continuous-time random-walk (CTRW) diffusion model, together with a quartile histogram analysis, for assessing glioma malignancy by probing tissue heterogeneity as well as cellularity. In this prospective study, 91 patients (40 females, 51 males) with histopathologically proven gliomas underwent MRI at 3 T. The cohort included 42 grade II (GrII), 19 grade III (GrIII) and 29 grade IV (GrIV) gliomas. Echo-planar diffusion-weigh...
1 CitationsSource
#2Karen Keating (Bayer AG: Bayer HealthCare Pharmaceuticals)H-Index: 11
Last. Brian Cuffel (Bayer AG: Bayer HealthCare Pharmaceuticals)H-Index: 2
view all 6 authors...
The results from basket trials utilized to gain regulatory approval of tumor-agnostic therapies can be difficult to interpret without the context of a comparator arm. We describe the role and effic...
Source
#1Emilie T. Reas (UCSD: University of California, San Diego)H-Index: 13
#2Donald J. Hagler (UCSD: University of California, San Diego)H-Index: 88
Last. Linda K. McEvoy (UCSD: University of California, San Diego)H-Index: 66
view all 6 authors...
Abstract Cytoarchitectural brain changes within gray matter and fiber tracts during normal aging remain poorly characterized, and it is unclear whether rates and patterns of brain aging differ by sex. This study used restriction spectrum imaging (RSI) to examine associations between age and brain microstructure in 147 community-dwelling participants (aged 56-99). Widespread associations with older age in multiple diffusion compartments, including increased free water, decreased restricted and hi...
2 CitationsSource
#1Anna Latysheva (Oslo University Hospital)H-Index: 3
#2Oliver Geier (Oslo University Hospital)H-Index: 16
Last. Andres Server (Oslo University Hospital)H-Index: 20
view all 8 authors...
PURPOSE We studied the ability of Restriction Spectrum Imaging (RSI), a novel advanced diffusion imaging technique, to estimate levels of cellularity in different glioblastoma regions, evaluated their prognostic value compared with established clinical diffusion metrics such as fractional anisotropy (FA) and mean diffusivity (MD). METHODS Forty-two patients with untreated glioblastoma, IDH-wildtype, were examined with an advanced MRI tumor protocol. The region of interest (ROI) was obtained from...
2 CitationsSource
#1Thais C. MussiH-Index: 14
#2Ronaldo Hueb BaroniH-Index: 18
Last. Antonio C. Westphalen (UCSF: University of California, San Francisco)H-Index: 31
view all 4 authors...
Multiparametric magnetic resonance (MR) imaging of the prostate is an excellent tool to detect clinically significant prostate cancer, and it has widely been incorporated into clinical practice due to its excellent tissue contrast and image resolution. The aims of this article are to describe the prostate MR imaging technique for detection of clinically significant prostate cancer according to PI-RADS v2.1, as well as alternative sequences and basic aspects of patient preparation and MR imaging ...
2 CitationsSource
#1Seyed Ali Nabavizadeh (UPenn: University of Pennsylvania)H-Index: 11
#2Jeffrey B. WareH-Index: 9
Last. Ronald L. WolfH-Index: 36
view all 3 authors...
Magnetic resonance imaging (MRI) has been the cornerstone of imaging of brain tumors in the past 4 decades. Conventional MRI remains the workhorse for neuro-oncologic imaging, not only for basic information such as location, extent, and navigation but also able to provide information regarding proliferation and infiltration, angiogenesis, hemorrhage, and more. More sophisticated MRI sequences have extended the ability to assess and quantify these features; for example, permeability and perfusion...
1 CitationsSource